TherapeuticsMD, Inc. Cash And Cash Equivalents At Carrying Value

• TherapeuticsMD, Inc. showed an increase of +16.9% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
• This data is from TherapeuticsMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
• XBRL data for this metric is available from 2010 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2009: $165.00 | Q3 2010: $23.9 thousand | Q4 2010: $422.9 thousand | Q1 2011: $18.5 thousand | Q2 2011: $78.3 thousand | Q3 2011: $153.9 thousand | Q4 2011: $126.4 thousand | Q1 2012: $195.2 thousand | Q2 2012: $1.33 million | Q3 2012: $154.2 thousand | Q4 2024: $5.06 million | Q1 2025: $5.75 million.
• Over the full 4 years of available data (2010 to 2024), TherapeuticsMD, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,096.2%.
• Historical annual values: Fiscal year 2024: $5.06 million | Fiscal year 2023: $4.33 million | Fiscal year 2011: $126.4 thousand | Fiscal year 2010: $422.9 thousand.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026